This article requires a subscription to view the full text. If you have a subscription you may use the login form below to view the article. Access to this article can also be purchased.
The article by Peltz et al.1 provides a nice example of differences in neurodegenerative biomarkers which can be found in patients with chronic traumatic brain injury (TBI) using blood samples enriched for CNS-derived exosomes. However, these differences seem driven more by the presence of cognitive impairment (CI) rather than the history of TBI itself. Based on the cohort studied (older veterans), there is no proven causality demonstrating that the CI in the TBI-CI group is actually driven by the remote TBI, which occurred decades previously. This could be an independent clinical finding in the veterans. Because the control group and the TBI-no-CI group did not differ in any of the biomarkers, it seems that the main driver of differences is cognitive impairment, which could be independent from the TBI even in the TBI-CI group. This article has some overlap with a recent study from this group, in which Aβ42 was reported to be elevated for decades after TBI.2 This is not the case in this article, with no clear explanation. One wonders the utility of these biomarkers in a clinical setting because they do not clarify the causes of the CI and are not specific to TBI.
Footnotes
Author disclosures are available upon request (journal{at}neurology.org).
- © 2021 American Academy of Neurology
AAN Members
We have changed the login procedure to improve access between AAN.com and the Neurology journals. If you are experiencing issues, please log out of AAN.com and clear history and cookies. (For instructions by browser, please click the instruction pages below). After clearing, choose preferred Journal and select login for AAN Members. You will be redirected to a login page where you can log in with your AAN ID number and password. When you are returned to the Journal, your name should appear at the top right of the page.
AAN Non-Member Subscribers
Purchase access
Letters: Rapid online correspondence
REQUIREMENTS
You must ensure that your Disclosures have been updated within the previous six months. Please go to our Submission Site to add or update your Disclosure information.
Your co-authors must send a completed Publishing Agreement Form to Neurology Staff (not necessary for the lead/corresponding author as the form below will suffice) before you upload your comment.
If you are responding to a comment that was written about an article you originally authored:
You (and co-authors) do not need to fill out forms or check disclosures as author forms are still valid
and apply to letter.
Submission specifications:
- Submissions must be < 200 words with < 5 references. Reference 1 must be the article on which you are commenting.
- Submissions should not have more than 5 authors. (Exception: original author replies can include all original authors of the article)
- Submit only on articles published within 6 months of issue date.
- Do not be redundant. Read any comments already posted on the article prior to submission.
- Submitted comments are subject to editing and editor review prior to posting.
